Clinical Trials Browser

Phase 1/2 × Tenofovir × 1 year × Clear all

NCT07133776 2025-08-21

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

Phase 1/2 Not yet recruiting

Infections, Epstein-Barr Virus Infections